Kewaunee Scientific Full Year 2025 Earnings: EPS: US$3.99 (vs US$6.51 in FY 2024)

Simply Wall St · 07/07 10:07

Kewaunee Scientific (NASDAQ:KEQU) Full Year 2025 Results

Key Financial Results

  • Revenue: US$240.5m (up 18% from FY 2024).
  • Net income: US$11.4m (down 39% from FY 2024).
  • Profit margin: 4.7% (down from 9.2% in FY 2024). The decrease in margin was driven by higher expenses.
  • EPS: US$3.99 (down from US$6.51 in FY 2024).
revenue-and-expenses-breakdown
NasdaqGM:KEQU Revenue and Expenses Breakdown July 7th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Domestic segment contributing a total revenue of US$180.0m (75% of total revenue). Notably, cost of sales worth US$171.6m amounted to 71% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$50.2m (87% of total expenses). Explore how KEQU's revenue and expenses shape its earnings.

Kewaunee Scientific's share price is broadly unchanged from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 4 warning signs for Kewaunee Scientific that you need to be mindful of.